BioMed Realty and TransMedics Announce 498,000-Square-Foot Lease at Assembly Innovation Park

SAN DIEGO & SOMERVILLE, Mass.--(BUSINESS WIRE)--Jan 12, 2026--

BioMed Realty, the largest privately-owned operator of real estate for the life science and technology industries, and TransMedics Group, Inc. (“TransMedics”, ticker: TMDX), a publicly traded medical technology company transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced that TransMedics has entered into a full building, 498,000-square-foot lease at Assembly Innovation Park, a premier life sciences development in Somerville, Massachusetts developed by BioMed Realty.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112803139/en/

The recently constructed 12-story commercial research and development facility will serve as TransMedics’ new global headquarters and manufacturing hub. The building, which is LEED ® Platinum and WELL certified, was specifically constructed to support both operational efficiency and workforce wellbeing. In addition to leasing 100% of the newly developed building for 16 years, TransMedics acquired the adjacent land parcel and portion of the parking structure within the campus to support future growth.

“We selected our new headquarters to support the full scale and complexity of our mission,” said Waleed Hassanein, M.D., President and CEO of TransMedics. "Our innovation will accelerate and thrive in this world-class facility that BioMed Realty built. It provides the infrastructure, flexibility, and long-term growth capacity we need to support our teams and the broader transplant community as we continue to advance life-saving transplant technologies and scale our impact globally.”

For more than 20 years, BioMed Realty has specialized in serving innovative life science companies, drawing on over 250 years of seasoned executive experience, to design a best-in-class building with an exceptional amenity package, large floor plates and an ability to accommodate robust programming requirements.

Bill Kane, President, East Coast and U.K. Markets at BioMed Realty, said: "We are delighted to welcome TransMedics to BioMed Realty’s highly differentiated Assembly Innovation Park campus. Led by our team of multidisciplinary experts, BioMed’s hands-on approach allows us to create and manage spaces that support our tenants’ most strategic initiatives."

Situated in Somerville’s mixed-use urban development area known as Assembly Square, and with its close proximity to Interstate 93 and the MBTA Orange Line, Assembly Innovation Park offers exceptional access and visibility to Greater Boston’s leading academic institutions, clinical centers and life sciences talent base.

In addition, Colleen O’Connor, Executive Vice President, Market Lead, East Coast & UK Markets at BioMed Realty, said: “At BioMed Realty, our purpose is to deliver mission-critical infrastructure that enables innovators to focus on advancing technology to improve human health. The Assembly Innovation Park campus was designed to provide flexibility and operational resilience that companies like TransMedics need to accelerate innovation and change lives.”

About BioMed Realty
BioMed Realty is the largest privately owned operator of real estate for the life science and technology industries in the United States and United Kingdom. The Company operates 17.3 million square feet of purpose-built laboratory and office space across the world’s top innovation hubs, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder, and Cambridge, U.K. With an additional 1.5 million square feet of Class A properties under development, BioMed Realty delivers flexible, reliable, and sustainable environments designed to accelerate discovery and keep world-changing work moving. Backed by more than 20 years of experience and the strength of being a Blackstone Real Estate portfolio company, BioMed Realty provides the confidence and partnership that fuel life-enhancing and world-changing innovation. To learn more, visit www.biomedrealty.com.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Assembly Innovation Park

BUFFALO, N.Y. (AP) — With highly prized prospect Gavin McKenna as the centerpiece, the NHL has selected the Buffalo Sabres to host its annual draft in June, a person with knowledge of the decision told The Associated Press.

The person spoke late last week on condition of anonymity because the league had yet to reveal its plans. The news was first reported by ESPN.

The formal announcement will be made during a news conference that will include NHL Commissioner Gary Bettman, and held in Buffalo on Monday night before the Sabres play Florida.

The draft date has already been set for June 26-27, with the league going with a decentralized format for a second straight year. The format features prospects and their families attending the draft, while team executives make the picks from their home markets.

The draft in Buffalo will be held at the Sabres home arena, KeyBank Center, the person said. That’s a switch from last year, when the two-day event was held at the Peacock Theater in Los Angeles.

Buffalo has also been home to the NHL’s annual pre-draft combine since 2015, and will once again host the league's top prospects this spring. This will mark the fourth time the Sabres host the draft, with the previous time being in 2016 when Auston Matthews was selected No. 1 by the Toronto Maple Leafs.

This time, all eyes will be on McKenna, the Penn State freshman forward who has long been projected to be the 2026 draft’s No. 1 pick.

The 18-year-old McKenna is from Whitehorse, Yukon, and made a major splash this summer when he elected to leave the Canadian Hockey League after two-plus seasons in Medicine Hat, Alberta, and make the jump to Happy Valley. The move south came in the first offseason after the NCAA lifted its longtime ban in making CHL players eligible to compete at the college ranks.

McKenna has been labeled a “generational talent,” and regarded as the 2026 draft’s top prospect since 2024.

McKenna ranks fourth on the Nittany Lions and seventh among NCAA freshmen with four goals and 15 assists for 19 points in 18 games.

The college ranks are considered more challenging because a majority of players are 19 and older, as opposed to the CHL where the age range is 16 to 20.

As a member of Canada’s bronze medal-winning team at the recent world junior championships, McKenna finished the tournament second with 10 points (four goals, six assists) in seven games.

McKenna thrived at Medicine Hat where he had 91 goals and 198 assists for 289 points in 158 career games. Last season, he failed to register a point in just four outings, while closing the year with a 45-game point streak in which McKenna combined for 32 goals and 100 points.

AP NHL: https://apnews.com/hub/nhl

Canada's Gavin McKenna speaks to media following a practice during the IIHF World Junior Championship, in Minneapolis on Tuesday, Dec. 30, 2025. (Christopher Katsarov/The Canadian Press via AP)

Canada forward Gavin McKenna (9) controls the puck during the second period of an IIHF World Junior Hockey Championship bronze medal game against Finland, Monday, Jan. 5, 2026, in St. Paul, Minn. (AP Photo/Matt Krohn)